Response to peginterferon-alpha 2b and ribavirin in Japanese patients with chronic hepatitis C genotype 1

被引：0
|
作者：
Tomoo Miyauchi
Tatsuo Kanda
Fumio Imazeki
Rintaro Mikata
Akinobu Tawada
Makoto Arai
Keiichi Fujiwara
Shingo Nakamoto
Shuang Wu
Takeshi Tanaka
Tatsuo Miyamura
Michio Kimura
Yasuo Hirai
Motohide Takashi
Shigeru Mikami
Nobuyuki Sugiura
Yutaka Natsuki
Ryosaku Azemoto
Noriaki Suzuki
Osamu Yokosuka
机构：
[1] Chiba University,Department of Medicine and Clinical Oncology, Graduate School of Medicine
[2] Social Insurance Funabashi Chuo Hospital,undefined
[3] Matsudo City Hospital,undefined
[4] Saiseikai Narashino Hospital,undefined
[5] Kikkoman Hospital,undefined
[6] National Hospital Organization Chiba Medical Center,undefined
[7] Sannou Hospital Medical Center,undefined
[8] Kimitsu Chuo Hospital,undefined
来源：
Hepatology International | 2013年 / 7卷
关键词：
Age; Gender; Genotype 1; HCV; Ribavirin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：144 / 152
页数：8
相关论文
共 50 条
  • [41] Adjuvant epoetin-β with peginterferon-α and ribavirin in Japanese ribavirin-intolerant relapsed patients with chronic hepatitis C genotype 2
    Enomoto, Masaru
    Morikawa, Hiroyasu
    Murakami, Yoshiki
    Tamori, Akihiro
    Kawada, Norifumi
    HEPATOLOGY RESEARCH, 2014, 44 (10) : E290 - E296
  • [42] Oral administration of lactoferrin enhances viral decline in patients with genotype-1B-related chronic hepatitis C treated with peginterferon α-2B plus ribavirin
    Kumagai, N.
    Tsunematsu, S.
    Hamano, H.
    Yamauchi, K.
    Tsuchimoto, K.
    BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 2006, 84 (03): : 385 - 385
  • [43] A meta-analysis that compares the use of either peginterferon-alpha 2a or peginterferon-alpha 2b plus ribavirin for HCV infection (vol 2, pg 99, 2010)
    Xiao N
    Shi S
    Zhuang H
    HEPATIC MEDICINE-EVIDENCE AND RESEARCH, 2011, 3 : 19 - 19
  • [44] Daclatasvir combined with peginterferon alfa-2a and ribavirin in Japanese patients infected with hepatitis C genotype 1
    Izumi, Namiki
    Yokosuka, Osamu
    Kawada, Norifumi
    Osaki, Yukio
    Yamamoto, Kazuhide
    Sata, Michio
    Ishikawa, Hiroki
    Ueki, Tomoko
    Hu, Wenhua
    McPhee, Fiona
    Hughes, Eric A.
    Kumada, Hiromitsu
    ANTIVIRAL THERAPY, 2014, 19 (05) : 501 - 510
  • [45] Cost-effectiveness of combination peginterferon α-2a and ribavirin compared with interferon α-2b and ribavirin in patients with chronic hepatitis C
    Sullivan, SD
    Jensen, M
    Bernstein, DE
    Hassanein, TI
    Foster, GR
    Lee, SS
    Cheinquer, H
    Craxi, A
    Cooksley, G
    Klaskala, W
    Pettit, K
    Patel, KK
    Green, J
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (08): : 1490 - 1496
  • [46] Cost effectiveness of peginterferon α-2b plus ribavirin versus interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C
    Siebert, U
    Sroczynski, G
    Rossol, S
    Wasem, J
    Ravens-Sieberer, U
    Kurth, BM
    Manns, MP
    McHutchison, JG
    Wong, JB
    GUT, 2003, 52 (03) : 425 - 432
  • [47] PhII proof of concept study of celgosivir in combination with peginterferon α-2b and ribavirin in chronic hepatitis C genotype-1 non-responder patients
    Kaita, K.
    Yoshida, E.
    Kunimoto, D.
    Anderson, F.
    Morris, S.
    Marotta, P.
    Scully, L.
    Peltekian, K.
    Enns, R.
    Diaz-Mitoma, F.
    Lee, S.
    Worobetz, L.
    Pankovich, J.
    Petersen, A. K.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S56 - S57
  • [48] Early HCV RNA changes in patients with chronic hepatitis C treated with peginterferon alfa 2b and ribavirin
    Gallegos-Orozco, JF
    Fuentes, AP
    Olivera-Martinez, MA
    Gutiérrez-Reyes, G
    Cortina, D
    Oregel, JA
    Pérez-Pruna, C
    Sixtos, MS
    Cruz-Castellanos, S
    Soto-Ramírez, LE
    Rodríguez-Díaz, R
    Fuentes-Romero, L
    Gutiérrez-Ruiz, MC
    Kershenobich, D
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2003, 55 (02): : 138 - 142
  • [49] Response-Guided Therapy of Peginterferon Alpha 2B Plus Ribavirin for Chronic Hepatitis C with Genotype 2 and a High Viral Road As An Effective Method Optimizing Therapy Duration
    Sato, Ken
    Horiuchi, Katsuhiko
    Naganuma, Atsushi
    Kosone, Takashi
    Yuasa, Kazuhisa
    Tahara, Hiroki
    Toyoda, Mitsuo
    Hagiwara, Satoshi
    Tojima, Hiroki
    Ichikawa, Takeshi
    Kakizaki, Satoru
    Takagi, Hitoshi
    Mori, Masatomo
    GASTROENTEROLOGY, 2009, 136 (05) : A485 - A486
  • [50] Efficacy and tolerability of peginterferon α-2a and α-2b in patients with chronic hepatitis C by genotype 1: A meta-analysis
    Coppola, N.
    Pisaturo, M.
    Sagnelli, C.
    Tonziello, G.
    Sagnelli, E.
    Angelillo, I. F.
    DIGESTIVE AND LIVER DISEASE, 2011, 43 : S94 - S94
12345